📰 Dal Bosco News
Dal Bosco News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Dal Bosco. Real-time updates on events, politics, business and more.
November 13, 2023
In this candid conversation, Bonamassa welcomes us to Nerdville to discuss his journey from 12-year-old prodigy to one of today’s most talked-about guitar players, what stops him being a traditional b
June 23, 2022
(RTTNews) - NRx Pharmaceuticals Inc. (NRXP) said Wednesday that on June 13, 2022, the plaintiffs in the securities class action lawsuit captioned ...
June 22, 2022
/PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals"), a clinical-stage, biopharmaceutical company, is pleased to announce that on...
June 22, 2022
/PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals"), a clinical-stage, biopharmaceutical company, is pleased to announce that on...
March 18, 2022
/PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP; NRXPW) securities between...
March 18, 2022
/PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP; NRXPW) securities between...
March 2, 2022
/PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP; NRXPW) securities between...
March 2, 2022
/PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP; NRXPW) securities between...
February 13, 2022
SAN DIEGO--(BUSINESS WIRE)--#NRXPWstock--Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP; NRXPW) securities between June 1, 2021 and November 4, 2021, both dates inclusive (the “Class Period”) have until March 21, 2022 to seek appointment as lead pla...
January 23, 2022
/PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP; NRXPW)...